These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33054296)

  • 41. Clinicopathological utility of miR-203a-3p in diagnosing colorectal cancer.
    Qasemi Rad M; Pouresmaeil V; Hosseini Mojahed F; Amirabadi A; Aalami AH
    Mol Biol Rep; 2022 Jul; 49(7):6975-6985. PubMed ID: 35511316
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MiR-485-5p as a potential biomarker and tumor suppressor in human colorectal cancer.
    Pan Y; Qin J; Sun H; Xu T; Wang S; He B
    Biomark Med; 2020 Feb; 14(3):239-248. PubMed ID: 31984757
    [No Abstract]   [Full Text] [Related]  

  • 43. MicroRNA-133b is regulated by TAp63 while no gene mutation is present in colorectal cancer.
    Chen Y; Zhang Y; He J; Fu Y; Lin C; Li X
    Oncol Rep; 2017 Mar; 37(3):1646-1652. PubMed ID: 28098895
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low-level serum miR-24-2 is associated with the progression of colorectal cancer.
    He HW; Wang NN; Yi XM; Tang CP; Wang D
    Cancer Biomark; 2018 Feb; 21(2):261-267. PubMed ID: 29171985
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic implications of serum microRNA-21 in colorectal cancer.
    Menéndez P; Padilla D; Villarejo P; Palomino T; Nieto P; Menéndez JM; Rodríguez-Montes JA
    J Surg Oncol; 2013 Nov; 108(6):369-73. PubMed ID: 23970420
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor-derived exosomal miRNA-320d as a biomarker for metastatic colorectal cancer.
    Tang Y; Zhao Y; Song X; Song X; Niu L; Xie L
    J Clin Lab Anal; 2019 Nov; 33(9):e23004. PubMed ID: 31420913
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
    Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS
    Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer.
    Wu X; Li S; Xu X; Wu S; Chen R; Jiang Q; Li Y; Xu Y
    Int J Clin Exp Pathol; 2015; 8(3):2840-51. PubMed ID: 26045793
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decreased Expression of MIR-134 and its Clinical Significance in Human Colorectal Cancer.
    Xie Y; Song J; Zong Q; Wang A; Yang Y; Liu F; Meng X
    Hepatogastroenterology; 2015 May; 62(139):615-9. PubMed ID: 26897940
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A panel of microRNA signature in serum for colorectal cancer diagnosis.
    Zhu M; Huang Z; Zhu D; Zhou X; Shan X; Qi LW; Wu L; Cheng W; Zhu J; Zhang L; Zhang H; Chen Y; Zhu W; Wang T; Liu P
    Oncotarget; 2017 Mar; 8(10):17081-17091. PubMed ID: 28177881
    [TBL] [Abstract][Full Text] [Related]  

  • 51. miR-429 identified by dynamic transcriptome analysis is a new candidate biomarker for colorectal cancer prognosis.
    Sun Y; Shen S; Tang H; Xiang J; Peng Y; Tang A; Li N; Zhou W; Wang Z; Zhang D; Xiang B; Ge J; Li G; Wu M; Li X
    OMICS; 2014 Jan; 18(1):54-64. PubMed ID: 24237355
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Circulating miR-103 and miR-720 as novel serum biomarkers for patients with colorectal cancer.
    Nonaka R; Miyake Y; Hata T; Kagawa Y; Kato T; Osawa H; Nishimura J; Ikenaga M; Murata K; Uemura M; Okuzaki D; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
    Int J Oncol; 2015 Sep; 47(3):1097-102. PubMed ID: 26134152
    [TBL] [Abstract][Full Text] [Related]  

  • 53. miRNA-503 Promotes Tumor Progression and Is Associated with Early Recurrence and Poor Prognosis in Human Colorectal Cancer.
    Noguchi T; Toiyama Y; Kitajima T; Imaoka H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Toden S; Kusunoki M
    Oncology; 2016; 90(4):221-31. PubMed ID: 26999740
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients.
    Du M; Liu S; Gu D; Wang Q; Zhu L; Kang M; Shi D; Chu H; Tong N; Chen J; Adams TS; Zhang Z; Wang M
    Carcinogenesis; 2014 Dec; 35(12):2723-30. PubMed ID: 25239640
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased expression of miR-552 acts as a potential predictor biomarker for poor prognosis of colorectal cancer.
    Wang N; Liu W
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):412-416. PubMed ID: 29424898
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spalt-like transcription factor 4 as a potential diagnostic and prognostic marker of colorectal cancer.
    Wu HK; Liu C; Fan XX; Wang H; Zhou L
    Cancer Biomark; 2017 Aug; 20(2):191-198. PubMed ID: 28869451
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MicroRNA-935 acts as a prognostic marker and promotes cell proliferation, migration, and invasion in colorectal cancer.
    Huang Y; Xiao W; Jiang X; Li H
    Cancer Biomark; 2019; 26(2):229-237. PubMed ID: 31524145
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Up-regulation of mir-10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer.
    Jiang H; Liu J; Chen Y; Ma C; Li B; Hao T
    Cancer Med; 2016 Oct; 5(10):2932-2941. PubMed ID: 27592860
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MiR-489 suppresses tumor growth and invasion by targeting HDAC7 in colorectal cancer.
    Gao S; Liu H; Hou S; Wu L; Yang Z; Shen J; Zhou L; Zheng SS; Jiang B
    Clin Transl Oncol; 2018 Jun; 20(6):703-712. PubMed ID: 29071516
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Up-regulation of miR-592 correlates with tumor progression and poor prognosis in patients with colorectal cancer.
    Liu M; Zhi Q; Wang W; Zhang Q; Fang T; Ma Q
    Biomed Pharmacother; 2015 Feb; 69():214-20. PubMed ID: 25661360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.